2014 Public Report of Major League Baseball’s Joint Drug Prevention and Treatment Program

Press Release MLB & MLBPA

This report covers the time from the beginning of the 2013-2014 Major League Baseball off-season to the end of the 2014 Major League Baseball post-season. As per agreement between the Office of the Commissioner of Baseball and the Major League Baseball Players Association, the following report is specific to players who compose 40-man rosters for Major League Baseball Clubs.

1) The total number of drug tests that were conducted for the presence of Performance Enhancing Substances and/or Stimulants during the time listed above was 7,929 tests. The number of urine samples that were collected and analyzed for Performance Enhancing Substances and/or Stimulants was 6,394. The number of blood samples that were collected and analyzed for the presence of human growth hormone was 1,535.

2) Twelve tests were reported by the testing laboratory for having an adverse analytical finding that resulted in discipline. Two were for Performance Enhancing Substances, and ten were for Stimulants. The substances reported were as follows:

Performance Enhancing Substances (2)
Boldenone: 1
Methandienone: 1
Stimulants (10)
Adderall: 8
Methylhexaneamine: 1
Modafanil: 1

3) There was one (1) non-analytical positive resulting in discipline.

4) 113 Therapeutic Use Exemptions were granted. The diagnoses were as follows:
Attention Deficit Disorder: 112
Hypogonadism: 1